Mobile Menu - OpenMobile Menu - Closed

Congressman Lloyd Doggett

Representing the 35th District of Texas

Connect

Media Center

Latest News

March 18, 2019
Last week, Democratic Representative Lloyd Doggett of Texas and Democratic Senator Sheldon Whitehouse of Rhode Island introduced the No Tax Breaks for Outsourcing Act and the Stop Tax Haven Abuse Act. These bills aim to close loopholes stemming from the 2017 GOP tax bill that incentivize companies to offshore their assets overseas—or at least to make it appear that their profits were earned outside the U.S. Doggett and Whitehouse introduced similar legislation last year.
March 14, 2019
House Democrats grilled Treasury Secretary Steven Mnuchin on Thursday about how he would handle a request from Congress for the president's tax returns at a Capitol Hill budget hearing.
March 14, 2019
Steven Mnuchin, the Treasury secretary, signaled on Thursday that he would likely block a congressional request to obtain President Trump’s tax returns on privacy grounds, setting up a potential legal battle if Democrats follow through with plans to request those documents.
March 14, 2019
Washington, D.C. – Today, Congressman Lloyd Doggett (D-TX) questioned U.S. Treasury Secretary Steven Mnuchin in the House Ways and Means Committee. Rep. Doggett began by noting the Secretary’s prior non-responsiveness on several matters. After the hearing, Doggett added, “What he said today was little more than mumble jumble doubletalk.”
March 14, 2019
Washington, D.C. – Today, Congressman Lloyd Doggett (D-TX) spoke on the House floor urging passage of a resolution in support of making Special Counsel Mueller’s report available to the public and to Congress. You can watch his speech here or read it below. Eleven months ago, Rep. Doggett introduced legislation to ensure that the work of the Special Counsel is not suppressed. Rep. Doggett is also helping lead the charge to obtain Trump’s personal and business tax returns.
March 13, 2019
Representative Lloyd Doggett and Senator Sheldon Whitehouse are introducing two bills Wednesday that would effectively repeal some provisions of the Republican tax overhaul of 2017 that the Democrats say encourage outsourcing.
March 13, 2019
Washington, DC — Today, Congressman Lloyd Doggett (D-TX), a member of the Ways and Means Committee, and Senator Sheldon Whitehouse (D-RI), a member of the Finance Committee, introduced the No Tax Breaks for Outsourcing Act and the Stop Tax Haven Abuse Act. Under the Trump Tax law, companies that ship jobs and invest overseas are eligible for special tax rates that may be half the domestic corporate tax rate and possibly even tax-free. The No Tax Breaks for Outsourcing Act would level the playing field for domestic companies by ensuring that multinationals pay the same tax rate on profits earned abroad as they do in the United States, ending these new tax incentives to outsource jobs and shift profits offshore.
March 7, 2019
House Democrats on Thursday took aim at one of the pharmaceutical industry’s key arguments as Congress considers how to address drug prices, questioning whether drugmakers are actually innovating in exchange for the high prices Americans pay.
Issues:
March 7, 2019
Washington, DC — Today, Chairman Doggett held a Ways and Means Health Subcommittee hearing on medicines in Medicare. Hearing from experts testifying to policy options and patient experience, it explored ways that Medicare can encourage affordability, competition, and access to medicines, as patients face a prescription drug affordability crisis. It featured expert witnesses Frederick Isasi, Executive Director, Families USA; Robin Feldman, Director of the Institute for Innovation Law, UC Hastings College of Law; Ameet Sarpatwari, Assistant Director of the Program on Regulation, Therapeutics, and Law (PORTAL) Harvard Medical School; Amy Kapczysnki, Co-Director of the Global Health Justice Partnership, Yale Law School; and Douglas Holtz-Eakin, President, American Action Forum.
March 7, 2019
From News 4 San Antonio on our hearing today on soaring Rx drug prices & promoting competition to ensure access to medicines:
Issues:

Pages